Related Experiment Video

Updated: Nov 17, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K

Cancer vaccines: An unkept promise?

Vignesh Kamath1

  • 1ADPL, Bengaluru, Karnataka, India.

Drug Discovery Today
|February 18, 2021
PubMed

Insights

Cancer vaccines showed promise but failed to improve survival due to cancer cell resistance. This review explores vaccine types, resistance mechanisms, and potential combination therapies like monoclonal antibodies (mAbs) and RNA interference (RNAi).

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Cancer vaccines were once considered a significant breakthrough in cancer treatment.
  • Despite stimulating immune responses and demonstrating safety, early cancer vaccines did not improve median survival times in clinical trials.
  • A major obstacle identified was the inherent resistance of cancer cells to immune responses.

Purpose of the Study:

  • To review various types of cancer vaccines and their design strategies.
  • To elucidate the mechanisms by which cancer cells develop resistance to immune attack.
  • To explore how adjunctive therapies, such as monoclonal antibodies (mAbs) and RNA interference (RNAi) (siRNA/shRNA), can overcome cancer vaccine limitations.

Main Methods:

  • Literature review of cancer vaccine development and clinical trial outcomes.
  • Analysis of immunological resistance mechanisms in cancer.
  • Exploration of complementary therapeutic strategies including monoclonal antibodies and RNA interference.

Main Results:

  • Cancer vaccines have historically faced challenges in improving patient survival.
  • Cancer cell resistance to immune surveillance is a critical factor limiting vaccine efficacy.
  • Emerging therapies offer potential to enhance cancer vaccine effectiveness.

Conclusions:

  • Overcoming cancer cell immune resistance is crucial for advancing cancer vaccine therapy.
  • Combination strategies involving cancer vaccines with agents like mAbs and RNAi hold promise for future cancer treatment.
  • Further research into synergistic therapeutic approaches is warranted to improve patient outcomes.

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.1K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.7K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
621
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
856
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K